| Financial Year |
March 31 2023 |
| Monetary Funds |
480,850,952.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,491,500.00 |
| Accounts Receivable |
552,304,860.87 |
| Advances to Suppliers |
34,944,237.84 |
| Other Receivables |
4,776,382.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,406,706,480.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,743,662.46 |
| Total Current Assets |
2,672,950,733.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
108,428,648.42 |
| Investment Properties |
10,775,124.88 |
| Fixed Assetes |
1,276,260,022.71 |
| Under-construction Projects |
29,591,642.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
435,540,115.76 |
| R&D expenses |
6,336,579.12 |
| Goodwill |
2,832,963.49 |
| Long-Term Deferred and Prepaid Expenses |
27,940,009.47 |
| Deferred Income Tax Assets |
14,656,223.59 |
| Other Non-Current Assets |
233,283,033.14 |
| Sub-Total of Non-Current Assets |
2,152,540,255.46 |
| Total Assets |
4,825,490,988.75 |
| Short-Term Loans |
575,675,898.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
776,197,000.00 |
| Accounts Payable |
96,862,017.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,751,612.46 |
| Taxes Payable |
20,020,494.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,156,796.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
236,968,165.64 |
| Other Current Liabilities |
1,417,396.63 |
| Sub-Total of Current Liabilities |
1,787,952,432.27 |
| Long-term Loans |
778,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
76,170,200.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,858,886.26 |
| Deferred Income Tax Liabilities |
14,077,859.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
995,545,631.62 |
| Total Liabilities |
2,783,498,063.89 |
| Paid-In Capital(Or Share Stock) |
924,167,436.00 |
| Capital Surplus |
579,729,165.44 |
| Surplus Reserve |
246,447,720.44 |
| LESS:Treasury Stock |
840,195.67 |
| Undistributed Profits |
279,039,398.62 |
| Minority Stockholder's Interest |
3,894,741.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,038,098,182.91 |
| Owner's Equity（Stockholder's Equity） |
2,041,992,924.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,825,490,988.75 |
